TAPIMMUNE INC. (NASDAQ:TPIV) Files An 8-K Departure of Directors or Certain Officers; Election of Directors ... - Market Exclusive

TAPIMMUNE INC. (NASDAQ:TPIV) Files An 8-K Departure of Directors or Certain Officers; Election of Directors …Market Exclusiveto the Warrant Amendment Agreement with the Warrant Amendment Entities, the Warrant Amendment Entities were issued an aggregate of 166,667 additional shares of Company common stock and new five-year warrants to purchase an aggregate of … and more …read more … Continue reading

Palatin Technologies Announces Proposed Public Offering of Common Stock and Warrants - PR Newswire (press release)

Palatin Technologies Announces Proposed Public Offering of Common Stock and WarrantsPR Newswire (press release)30, 2016 /PRNewswire/ — Palatin Technologies, Inc. (“Palatin”) (NYSE MKT: PTN) today announced that it has commenced an underwritten public offering, subject to market and other conditions, to issue and sell shares of its common stock and warrants to … and more …read more … Continue reading

UPDATE: Skyline Medical (SKLN) Closes Offering of Common Stock and Warrants for Proceeds of $1.98M - StreetInsider.com

UPDATE: Skyline Medical (SKLN) Closes Offering of Common Stock and Warrants for Proceeds of $1.98MStreetInsider.comThe offering consists of 756,999 shares of common stock priced at $2.62 per share and five-year warrants for 756,999 shares of common stock that become exercisable in six months, with a strike price of $4.46 per share. The net proceeds from the sale of … and more …read more … Continue reading

Skyline Medical (SKLN) Closes Offering of Common Stock and Warrants for Proceeds of $1.98M - StreetInsider.com

Skyline Medical (SKLN) Closes Offering of Common Stock and Warrants for Proceeds of $1.98MStreetInsider.comThe offering consists of 756,999 shares of common stock priced at $2.62 per share and five-year warrants for 756,999 shares of common stock that become exercisable in six months, with a strike price of $4.46 per share. The net proceeds from the sale of … and more …read more … Continue reading

Trump Makes the U.S. Stock Market Great Again

Technical analyst Clive Maund analyzes the charts since Trump’s win and sees a positive picture for the U.S. stock market. The broad U.S. stock market actually looks better overall than it has done for several years, which may come as a surprise considering it has been in a bull market since as far back as early 2009. On the 10-year chart for the S&P 500 Index we can see that a potential top area developed from early 2015 through the middle of this year, which has now been aborted by recent gains that have seen it break clear above resistance at earlier highs. This index remains within the big parallel channel that started to form back in 2010–2011 and appears to have its sights set on a run to the upper boundary of the channel again, which will result in BIG gains from the current level. While we can speculate about the fundamental reason or reasons for such a move—a Trump spending spree, hot money flowing out of embattled Europe and possibly the Mid-East and Japan into the U.S., and helicopter money—such pondering is largely a waste of time; the chart says the market is set to advance and quite a lot, and that’s what matters. This is a big change from several months back or even several weeks back, when it looked toppy and vulnerable. The 4-year chart enables us to see how the market gradually rounded over beneath a giant Dome pattern, but then broke clear above it … Continue reading

Cellectar Biosciences Announces Successful Completion of $9.2 ... - GlobeNewswire (press release)

Cellectar Biosciences Announces Successful Completion of $9.2 …GlobeNewswire (press release)MADISON, Wis., Nov. 29, 2016 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (Nasdaq:CLRB) (“Cellectar” or the “company”), an oncology-focused, clinical …Biotech Stocks To Put On Your Watch List: Cellectar Biosciences, Inc. (NASDAQ:CLRB), Threshold Pharmaceuticals …The Voice RegistrarBiotech Stocks Worth Chasing: Cellectar Biosciences, Inc. (CLRB), Ocera Therapeutics, Inc. (OCRX)The Independent RepublicCellectar Biosciences, Inc. (NASDAQ:CLRB) Announces Pricing of …KC Register all 16 news articles …read more … Continue reading